Guosheng Wu

2.1k total citations · 1 hit paper
44 papers, 1.6k citations indexed

About

Guosheng Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Guosheng Wu has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Guosheng Wu's work include Natural product bioactivities and synthesis (5 papers), Cancer-related molecular mechanisms research (4 papers) and Autophagy in Disease and Therapy (4 papers). Guosheng Wu is often cited by papers focused on Natural product bioactivities and synthesis (5 papers), Cancer-related molecular mechanisms research (4 papers) and Autophagy in Disease and Therapy (4 papers). Guosheng Wu collaborates with scholars based in China, Macao and United States. Guosheng Wu's co-authors include Yitao Wang, Jin‐Jian Lu, Xiuping Chen, Jiajie Guo, Jiaolin Bao, Mingqing Huang, Xiuping Chen, Zengtao Xu, Yuanye Dang and Wenshan Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Surgery.

In The Last Decade

Guosheng Wu

42 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-cancer natural products isolated from chinese medicinal herbs

2011 328 citations Jin‐Jian Lu, Mingqing Huang et al. Chinese Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guosheng Wu China	22	927	375	227	206	201	44	1.6k
Shih-Lan Hsu Taiwan	23	810 0.9×	246 0.7×	243 1.1×	184 0.9×	241 1.2×	38	1.6k
Hwa‐Jin Chung South Korea	27	863 0.9×	269 0.7×	139 0.6×	143 0.7×	191 1.0×	62	1.7k
Bum Sang Shim South Korea	26	1.1k 1.1×	193 0.5×	275 1.2×	262 1.3×	383 1.9×	62	1.9k
Chao-Lin Kuo Taiwan	24	1.0k 1.1×	197 0.5×	184 0.8×	224 1.1×	158 0.8×	39	1.8k
Jo‐Hua Chiang Taiwan	31	1.3k 1.4×	316 0.8×	209 0.9×	337 1.6×	286 1.4×	56	2.3k
Sunga Choi South Korea	25	1.5k 1.6×	311 0.8×	150 0.7×	180 0.9×	222 1.1×	57	2.2k
Hyun Lim South Korea	24	870 0.9×	402 1.1×	187 0.8×	176 0.9×	115 0.6×	54	1.7k
Sivanandhan Dhanalakshmi United States	24	1.2k 1.3×	404 1.1×	290 1.3×	202 1.0×	241 1.2×	36	2.1k
Shwu‐Bin Lin Taiwan	18	705 0.8×	390 1.0×	208 0.9×	177 0.9×	152 0.8×	39	1.4k
Chao‐Lin Kuo Taiwan	23	853 0.9×	313 0.8×	144 0.6×	157 0.8×	114 0.6×	58	1.5k

Countries citing papers authored by Guosheng Wu

Since Specialization

Citations

This map shows the geographic impact of Guosheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guosheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guosheng Wu more than expected).

Fields of papers citing papers by Guosheng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guosheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guosheng Wu. The network helps show where Guosheng Wu may publish in the future.

Co-authorship network of co-authors of Guosheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guosheng Wu. A scholar is included among the top collaborators of Guosheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guosheng Wu. Guosheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ting, Jie Wang, Ying Liang, et al.. (2025). Discovery of Yersinia LcrV as a novel biased agonist of formyl peptide receptor 1 to bi-directionally modulate intracellular kinases in triple-negative breast cancer. Acta Pharmaceutica Sinica B. 15(7). 3646–3662.

Li, Junqiang, Wei Zhang, Yifan Liu, et al.. (2025). Optimal Timing and Approaches for First Tangential Excision in Patients with ≥70% TBSA Burns. Annals of Surgery. 1 indexed citations

Wu, Guosheng, Ying Liang, Qian Zhang, et al.. (2024). Lipid droplet formation induced by icaritin derivative IC2 promotes a combination strategy for cancer therapy. Chinese Medicine. 19(1). 178–178.

Chen, Fang, et al.. (2023). Correlation of Plasma Adiponectin Levels and Adiponectin Gene Polymorphisms with Idiopathic Atrial Fibrillation. Cardiology. 149(2). 176–182. 1 indexed citations

Wang, Yixuan, et al.. (2023). Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition. Molecules. 28(3). 1109–1109. 13 indexed citations

Yang, Chen, Jie Mei, Die Hu, et al.. (2022). Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis. Cancer Cell International. 22(1). 202–202. 19 indexed citations

Zhang, Ying, Jianyong Zheng, Xiaomin Wang, et al.. (2019). Prognostic value of ABO blood group in a Chinese population in Northwest China region with curatively resected rectal cancer. Journal of Cancer. 10(26). 6584–6593. 4 indexed citations

Li, Ting, Zhenghai Tang, Wenshan Xu, et al.. (2015). Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells. European Journal of Pharmacology. 749. 81–88. 46 indexed citations

Chu, Dake, Shaojun Zhu, Jipeng Li, et al.. (2014). CD147 Expression in Human Gastric Cancer Is Associated with Tumor Recurrence and Prognosis. PLoS ONE. 9(6). e101027–e101027. 33 indexed citations

10.

Zheng, Jianyong, Chunsheng Xu, Dake Chu, et al.. (2014). Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis. Immunology Letters. 161(1). 13–19. 35 indexed citations

11.

Li, Ting, Wenshan Xu, Guosheng Wu, et al.. (2014). Platycodin D Induces Apoptosis, and Inhibits Adhesion, Migration and Invasion in HepG2 Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention. 15(4). 1745–1749. 52 indexed citations

12.

Xia, Qing, Yuchen Cai, Roujun Peng, et al.. (2013). The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition. International Journal of Oncology. 44(3). 735–744. 49 indexed citations

13.

Wu, Guosheng, Yuelin Song, Zhi‐Qi Yin, et al.. (2013). Ganoderiol A-Enriched Extract Suppresses Migration and Adhesion of MDA-MB-231 Cells by Inhibiting FAK-SRC-Paxillin Cascade Pathway. PLoS ONE. 8(10). e76620–e76620. 57 indexed citations

14.

Li, Ying‐Bo, Zhangfeng Zhong, Meiwan Chen, et al.. (2013). Bisdemethoxycurcumin Increases Sirt1 to Antagonizet-BHP-Induced Premature Senescence in WI38 Fibroblast Cells. Evidence-based Complementary and Alternative Medicine. 2013. 1–9. 14 indexed citations

15.

Wu, Guosheng, Jin‐Jian Lu, Jiajie Guo, et al.. (2013). Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacological Reports. 65(2). 453–459. 68 indexed citations

16.

Duan, Hongying, Guosheng Wu, Shuyan Li, et al.. (2012). E2F1 enhances 8-Chloro-adenosine-induced G2/M arrest and apoptosis in A549 and H1299 lung cancer cells. Biochemistry (Moscow). 77(3). 261–269. 4 indexed citations

17.

Xu, Wenshan, Yuanye Dang, Jiajie Guo, et al.. (2012). Furanodiene Induces Endoplasmic Reticulum Stress and Presents Antiproliferative Activities in Lung Cancer Cells. Evidence-based Complementary and Alternative Medicine. 2012. 1–8. 26 indexed citations

18.

Zheng, Jianyong, Dake Chu, Desheng Wang, et al.. (2012). Matrix metalloproteinase‐12 is associated with overall survival in Chinese patients with gastric cancer. Journal of Surgical Oncology. 107(7). 746–751. 23 indexed citations

19.

Zhong, Zhangfeng, Maggie Pui Man Hoi, Guosheng Wu, et al.. (2011). Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. Journal of Ethnopharmacology. 141(2). 721–727. 45 indexed citations

20.

Li, Shuyan, et al.. (2010). Calcium signal-initiated early activation of NF-κB in neurons is a neuroprotective event in response to kainic acid-induced excitotoxicity. Biochemistry (Moscow). 75(1). 101–110. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact